Neurocrine Biosciences
NBIXNeurocrine Biosciences is a publicly traded biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbena …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2024
All insider trades at Neurocrine Biosciences
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 4/15/2024 | Sell | Benevich, Eric | Chief Commercial Officer | $133.4 | $2,643,019 |
| 4/1/2024 | Sell | Delaet, Ingrid | Chief Regulatory Officer | $137.3 | $37,346 |
| 3/21/2024 | Sell | Delaet, Ingrid | Chief Regulatory Officer | $145.1 | $725,320 |
| 3/14/2024 | Sell | Morrow, George J. | Director | $139.4 | $5,576,710 |
| 3/14/2024 | Sell | Benevich, Eric | Chief Commercial Officer | $139.4 | $10,453,418 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)